Form 4 Filing by James Mulay for CG Oncology, Inc.

This Form 4 filing details transactions made by James Mulay, a director at CG Oncology, Inc. (CGON), on June 15, 2026. The transactions include the acquisition of 654 shares of Common Stock at $3.72 per share and the acquisition of 1310 shares of Common Stock at $12.59 per share. Concurrently, Mr. Mulay disposed of 654 shares of Common Stock at $60.12 per share and another 1310 shares of Common Stock at $60.12 per share. These sales were executed under a Rule 10b5-1 trading plan. The filing also reports the exercise and disposal of Director Stock Options. Specifically, 654 options were exercised and disposed of with an exercise price of $3.72, and 1310 options were exercised and disposed of with an exercise price of $12.59. Following these transactions, Mr. Mulay holds 0 shares directly and 2620 shares indirectly through options. The signature date was June 16, 2026.